Beam Therapeutics Inc header image

Beam Therapeutics Inc

BEAM

Equity

ISIN null / Valor 50337226

NASDAQ (2026-01-23)
USD 31.56-7.88%

Beam Therapeutics Inc
UMushroom community rating:

star star star star star
4.00 4 votes No rating yet
NegativeNeutralPositive

About company

Beam Therapeutics Inc is a biotechnology company focused on developing innovative gene editing technologies to treat a wide range of genetic diseases. The company's delivery strategy involves utilizing a suite of clinically validated technologies, including electroporation, nonviral, and viral delivery modalities, to efficiently and precisely edit genes. Beam Therapeutics Inc aims to revolutionize the field of gene editing by providing novel solutions for patients with genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.0%1Y
-28.9%3Y
-68.3%5Y

Performance

75.3%1Y
69.7%3Y
76.4%5Y

Volatility

Market cap

3203 M

Market cap (USD)

Daily traded volume (Shares)

2,122,383

Daily traded volume (Shares)

1 day high/low

26.41 / 24.77

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

4 votes
Performance:
starstarstarstarstar
3.75
Innovation:
starstarstarstarstar
3.25
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.75
Fabio Kull
Switzerland, 30 Oct 2025
star star star star star
promising biotech company focused on precise gene editing. The stock is innovative but risky
Carlos Mayes
United Kingdom, 21 Oct 2025
star star star star star
Strong growth currently
Ben Marshall
United Kingdom, 21 Oct 2025
star star star star star
Currently performing very well however has potential to fall off completely soon

EQUITIES OF THE SAME SECTOR

Klaviyo Inc
Klaviyo Inc Klaviyo Inc Valor: 129329789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.10%USD 25.62
Emerson Electric Co
Emerson Electric Co Emerson Electric Co Valor: 928215
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.72%USD 147.68
Fidelity National Information Services Inc
Fidelity National Information Services Inc Fidelity National Information Services Inc Valor: 1873824
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%USD 60.50
Synopsys Inc
Synopsys Inc Synopsys Inc Valor: 975377
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%USD 501.39
IVU Traffic Technologies AG
IVU Traffic Technologies AG IVU Traffic Technologies AG Valor: 1099895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 21.00
Jabil Inc
Jabil Inc Jabil Inc Valor: 71588
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%USD 243.14
AQ Group AB
AQ Group AB AQ Group AB Valor: 135165509
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%SEK 183.50
Mettler Toledo International Inc
Mettler Toledo International Inc Mettler Toledo International Inc Valor: 831090
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.21%USD 1,406.36
AMETEK Inc
AMETEK Inc AMETEK Inc Valor: 681997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.53%USD 220.74
Take-Two Interactive Software Inc
Take-Two Interactive Software Inc Take-Two Interactive Software Inc Valor: 622906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.92%USD 245.73